Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001209191-21-030815

Director acquired 46,218 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Yanai Shlomo Director 2021-05-06 Option exercise +46,218 53,740 D
Derivatives
Yanai Shlomo Director 2021-05-05 Grant or award · Restricted Stock Units +35,406 35,406 D
Yanai Shlomo Director 2021-05-06 Option exercise · Restricted Stock Units −46,218 0 D
Loading xslF345X03/doc4.xml…